ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a ...

Immutep halts TACTI-004 Phase III in first-line NSCLC due to futility; shares resume trading as cash runway extends beyond Q2 ...

Everest Metals eyes near-term production after bonanza-grade RC results at Mt Dimer Taipan, with 45,000t ROM and April 2026 ...

Felix Gold expands high-grade antimony at Treasure Creek, Alaska, with shallow intercepts up to 12.53% Sb and a gold halo, ...

Forte Energy clinches 143,368-acre Alaska NPR-A lease position; 2026 suspension cuts ~$430k fees, fueling farmouts as Harrier ...

Syrah Resources avoids US AD/CVD tariffs after ITC's negative ruling on Chinese graphite; Vidalia AAM sales may be delayed despite ready capacity.

DorsaVi kicks off 180-nm RRAM testing as it targets a 22-nm edge AI/robotics platform, boosting neuromorphic ambitions amid FY25 revenue decline.

Uranium rally as AI data centers and SMRs power multi-million tech PPAs; looming structural deficit puts uranium in focus for investors.

EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks. Raise: $904k via placement. New shares: 45.2m @ $0.02.

InteliCare inks $8.8m 5-year deal to roll out its predictive analytics IoT platform across mecwacare's Victorian facilities, largest contract yet.

Rumble Resources hits high-grade gold and tungsten at Western Queen, pushing 2026 MRE updates and Feasibility Study; multiple new intercepts boost upside.

Torque Metals taps ex-Spartan leadership to accelerate Paris Gold Project growth in WA, aiming a quick transition from ...